iSERA LIFESCIENCES share news, announcements and annual reports
BSE: 534920IT - SoftwareSmall Cap
iSERA LIFESCIENCES LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2013
Last close ₹143.90₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹143.90.
30 Oct: open ₹143.90, high ₹143.90, low ₹143.90
52-week range of traded prices to 30 Oct 2026
₹7.99Low, 30 Oct 2025₹151.05High, 17 Sep 2026
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹354 Cr3,450th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- −0.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 226
iSERA LIFESCIENCES board meetings
174 filed, newest first. Page 1 of 4.
Oct 2026
1 Oct · Board meeting
Meeting on 1 Oct 2026: preferential issue of shares
Sep 2026
Aug 2026
3 Aug · Board meeting
Meeting on 7 Aug 2026: quarterly results
Jun 2026
11 Jun · Board meeting
Meeting on 11 Jun 202611 Jun · Board meeting
May 2026
15 May · Board meeting
Meeting on 21 May 2026: audited results and quarterly results
Apr 2026
15 Apr · Board meeting
Meeting on 20 Apr 2026: preferential issue of shares
Mar 2026
10 Mar · Board meeting
Feb 2026
5 Feb · Board meeting
Meeting on 10 Feb 2026: quarterly results
Nov 2025
11 Nov · Board meeting
Meeting on 11 Nov 2025: rights issue of equity shares and rights issue10 Nov · Board meeting
Meeting on 13 Nov 2025: quarterly results
Oct 2025
16 Oct · Board meeting
16 Oct · Board meeting
Meeting on 16 Oct 2025: rights issue of equity shares and rights issue3 Oct · Board meeting
Meeting on 9 Oct 2025: rights issue of equity shares3 Oct · Board meeting
Sep 2025
29 Sep · Board meeting
Meeting on 3 Oct 2025: rights issue of equity shares
Jul 2025
29 Jul · Board meeting
Meeting on 1 Aug 2025: quarterly results
May 2025
27 May · Board meeting
Meeting on 30 May 2025: audited results
Mar 2025
25 Mar · Board meeting
Meeting on 25 Mar 202525 Mar · Board meeting
Feb 2025
3 Feb · Board meeting
Meeting on 10 Feb 2025: quarterly results
Nov 2024
6 Nov · Board meeting
Meeting on 13 Nov 2024: quarterly results
Oct 2024
Aug 2024
28 Aug · Board meeting
12 Aug · Board meeting
6 Aug · Board meeting
Meeting on 12 Aug 2024: quarterly results
May 2024
21 May · Board meeting
Meeting on 29 May 2024: audited results
Mar 2024
7 Mar · Board meeting
Meeting on 7 Mar 2024: preferential issue of shares, reduction of capital and scheme of arrangement